Inhibrx Biosciences, Inc. Quarterly Return On Equity in % from Q4 2023 to Q2 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Inhibrx Biosciences, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2023 to Q2 2025.
  • Inhibrx Biosciences, Inc. Return On Equity for the quarter ending June 30, 2025 was -138 %, a 109% decline year-over-year.
  • Inhibrx Biosciences, Inc. annual Return On Equity for 2024 was 1.24K %.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2025 -138 -1.76K -109% Apr 1, 2025 Jun 30, 2025
Q1 2025 1.1K +1.78K Jan 1, 2025 Mar 31, 2025
Q4 2024 1.24K +1.83K Oct 1, 2024 Dec 31, 2024
Q3 2024 1.45K Jul 1, 2024 Sep 30, 2024
Q2 2024 1.62K Apr 1, 2024 Jun 30, 2024
Q1 2024 -679 Jan 1, 2024 Mar 31, 2024
Q4 2023 -591 Oct 1, 2023 Dec 31, 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.